Gene engineered exosome reverses T cell exhaustion in cancer immunotherapy.

Authors:
Li P; Xie Y; Wang J; Bao C; Duan J and 11 more

Journal:
Bioact Mater

Publication Year: 2024

DOI:
10.1016/j.bioactmat.2024.01.008

PMCID:
PMC10825617

PMID:
38292412

Journal Information

Journal Title: Bioact Mater

Detailed journal information not available.

Publication Details

Subject Category: Materials Science, Biomaterials

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare no conflict of interest."

Evidence found in paper:

"This work was supported by the National Natural Science Foundation of China (No. 82173752 and No. 81874303). Peishan Li: Writing – original draft, Methodology, Investigation, Formal analysis, Data curation. Ying Xie: Writing – original draft, Methodology, Investigation. Jinling Wang: Writing – original draft, Validation, Methodology, Investigation, Formal analysis, Data curation. Chunjie Bao: Formal analysis, Data curation. Jialun Duan: Methodology, Investigation. Yixuan Liu: Methodology, Conceptualization. Qian Luo: Writing – original draft, Formal analysis. Jiarui Xu: Methodology. Yuxin Ren: Methodology. Min Jiang: Methodology, Formal analysis. Jianwei Li: Formal analysis. Haitao Guo: Methodology. Huihui Zhao: Methodology. Guiling Wang: Formal analysis. Yanqin Liang: Validation, Project administration, Formal analysis. Wanliang Lu: Writing – review & editing, Validation, Supervision, Resources, Project administration, Investigation, Funding acquisition, Conceptualization."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025